# Lightpath Technologies Inc: Form 10-Q for the period ended Dec 31, 2014

- Company: [Lightpath Technologies Inc](/companies/lpth.md) (CIK 889971)
- Form: 10-Q
- Filed: 2015-02-05
- Accepted by EDGAR: Feb 5, 2015, 16:33 ET
- Period: 2014-12-31
- Accession: 0001387131-15-000371
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/889971/000138713115000371/lpth-10q_123114.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/889971/000138713115000371/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2014-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2014-10-01 to 2014-12-31 | $3.4m | us-gaap:SalesRevenueGoodsNet |
| Revenue | 6 months, 2014-07-01 to 2014-12-31 | $6.0m | us-gaap:SalesRevenueGoodsNet |
| Cost of revenue | 3 months, 2014-10-01 to 2014-12-31 | $2.1m | us-gaap:CostOfGoodsSold |
| Cost of revenue | 6 months, 2014-07-01 to 2014-12-31 | $3.7m | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months, 2014-10-01 to 2014-12-31 | $1.3m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2014-07-01 to 2014-12-31 | $2.2m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2014-10-01 to 2014-12-31 | $1.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2014-07-01 to 2014-12-31 | $2.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2014-10-01 to 2014-12-31 | −$405.0k | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2014-07-01 to 2014-12-31 | −$915.5k | us-gaap:OperatingIncomeLoss |
| Net income | 3 months, 2014-10-01 to 2014-12-31 | $141.2k | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2014-07-01 to 2014-12-31 | −$437.8k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2014-10-01 to 2014-12-31 | $0.01 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2014-07-01 to 2014-12-31 | −$0.03 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2014-10-01 to 2014-12-31 | $0.01 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2014-07-01 to 2014-12-31 | −$0.03 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2014-10-01 to 2014-12-31 | 15,419,925 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2014-07-01 to 2014-12-31 | 14,297,807 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2014-07-01 to 2014-12-31 | −$309.8k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2014-07-01 to 2014-12-31 | $409.7k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2014-12-31 | $795.1k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2014-12-31 | $7.0m | us-gaap:AssetsCurrent |
| Total assets | at 2014-12-31 | $10.4m | us-gaap:Assets |
| Current liabilities | at 2014-12-31 | $3.1m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2014-12-31 | $3.4m | us-gaap:Liabilities |
| Shareholders' equity | at 2014-12-31 | $7.0m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 41,135 characters.

*The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of the LightPath. All statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere in this Quarterly Report on Form 10-Q for the quarter ended December 31, 2014 (the “Quarterly Report”), other than statements of historical facts, which address activities, events or developments that we expect or anticipate will or may occur in the future, including such things as future capital expenditures, growth, product development, sales, business strategy and other similar matters are forward-looking statements. These forward-looking statements are based largely on our current expectations and assumptions and are subject to a number of risks and uncertainties, many of which are beyond our control. Actual results could differ materially from the forward-looking statements set forth herein as a result of a number of factors, including, but not limited to, limited cash resources and the need for additional financing, our dependence on a few key customers, our ability to transition our business into new markets, our ability to increase sales and manage and control costs and other risks described in our reports on file with the SEC. In light of these risks and uncertainties, all of the forward-looking statements made herein are qualified by these cautionary statements and there can be no assurance that the actual results or developments anticipated by us will be realized. We undertake no obligation to update or revise any of the forward-looking statements contained herein.*

The discussions of our results as presented in this Quarterly Report include use of the terms “EBITDA” and “gross margin.” EBITDA is discussed below. Gross margin is determined by deducting the cost of sales from operating revenue. Cost of sales includes manufacturing direct and indirect labor, materials, services, fixed costs for rent, utilities and depreciation, and variable overhead. Gross margin should not be considered an alternative to operating income or net income, which are determined in accordance with GAAP. We believe that gross margin, although a non-GAAP financial measure is useful and meaningful to investors as a basis for making investment decisions. It provides investors with information that demonstrates our cost structure and provides funds for our total costs and expenses. We use gross margin in measuring the performance of our business and have historically analyzed and reported gross margin information publicly. Other companies may calculate gross margin in a different manner.

### Overview

### Historical:

We are in the business of manufacturing optical components and higher level assemblies including precision molded glass aspheric optics, proprietary high performance fiber optic collimators, GRADIUM glass lenses and other optical materials used to produce products that manipulate light. All the products we produce enable lasers and imaging devices to function more effectively.

In November 2005, we formed LPOI, a wholly-owned manufacturing subsidiary, located in Jiading, People’s Republic of China. Prior to December 2014, when we substantially completed the process of transitioning production from this facility to the LPOIZ facility, the manufacturing operations were housed in a 16,000 square foot facility located in the Jiading Industrial Zone near Shanghai. The LPOI facility will now be primarily used for sales and engineering functions.

In December 2013, we formed LPOIZ, a wholly-owned subsidiary that is housed in a 26,000 square foot leased manufacturing facility located in the New City district, in the Jiangsu province, of the People’s Republic of China. Production started at LPOIZ’s new manufacturing facility in April 2014. We expect this new facility to provide a lower cost structure for production of larger volumes of optical components and assemblies. We have substantially completed the process of transitioning production from the LPOI facility to the LPOIZ facility.

### Recent Initiatives:

In February 2015, we announced the implementation of strategic growth initiatives and an organizational optimization plan. Under these plans, we expect to be better positioned to accelerate our revenue growth and profitability, principally by the transition to a technical sales process that leverages the success of our existing demand-creation model. To align the organization for specific goals and accountability, an executive structure has been created with three direct reporting lines: Operations, China, and Finance. Technical and engineering staff will be more fully integrated with our sales force, and two new sales positions were created: Executive Sales Manager, combining the responsibility for all sales and marketing and, Marketing Manager. Organizations supporting aspheric visible lens products and our new line of infrared products were combined. Sales, marketing, engineering and quality will report to the newly created position of Executive Vice President-Operations.

Over the past five years we recorded a compounded annual revenue growth rate of approximately 10% for our core aspheric optical lens business, which excludes our new infrared product line and a large non-recurring order in support of the DARPA program. During this period, we invested to expand our high speed manufacturing capacity, enhanced our manufacturing, coating and finishing processes, and implemented a demand-creation model that leverages our low cost, high volume, superior quality production capabilities to not only take market share but, more importantly, to create new market opportunities.

These growth initiatives and organizational modifications are intended to further enhance our incremental organic growth position for our core aspheric lens business, prime our operations for the anticipated high growth of our new infrared products, and allow for the integration of strategic acquisitions. An ancillary benefit of these plans are an estimated annual reduction of operating expenses of 5% to 10% or savings of approximately $200,000 to $375,000 per year upon complete implementation. We are benefiting from a substantial increase in revenue generating opportunities and broader market applications as a result of our investments in technologies that decreased our lens production costs and expanded our production capacity. We believe we can further improve upon our track record of growth – and to do so far more profitably.

### How we operate:

We have continuing sales of two basic types: occasional sales via ad-hoc purchase orders of mostly standard product configurations (our “turns” business) and the more challenging and potentially more rewarding business of customer product development. In this latter type of business we work with customers to help them determine optical specifications and even create certain optical designs for them, including complex multi-component designs that we call “engineered assemblies.” This is followed by “sampling” small numbers of the product for the customers’ test and evaluation. Thereafter, should a customer conclude that our specification or design is the best solution to their product need; we negotiate and “win” a contract (sometimes called a “design win”) – whether of a “blanket purchase order” type or a supply agreement. The strategy is to create an annuity revenue stream that makes the best use of our production capacity as compared to the turns business, which is unpredictable and uneven. This annuity revenue stream can also generate low-cost, high-volume type orders. A key business objective is to convert as much of our business to the design win and annuity model as is possible. We face several challenges in doing so:

- Maintaining an optical design and new product sampling capability, including a high-quality and responsive optical design engineering staff;
- The fact that as our customers take products of this nature into higher volume, commercial production (for example, in the case of molded optics, this may be volumes over one million pieces per year) they begin to work seriously to reduce costs – which often leads them to turn to larger or overseas producers, even if sacrificing quality; and
- Our small business mass means that we can only offer a moderate amount of total productive capacity before we reach financial constraints imposed by the need to make additional capital expenditures – in other words, because of our limited cash resources and cash flow, we may not be able to service every opportunity that presents itself in our markets without arranging for such additional capital expenditures.

Despite these challenges to winning more “annuity” business, we nevertheless believe we can be successful in procuring this business because of our unique capabilities in optical design engineering that we make available on the merchant market, a market that we believe is underserved in this area of service offering. Additionally, we believe that we offer value to some customers as a source of supply in the United States should they be unwilling to commit their entire source of supply of a critical component to foreign merchant production sources. We also continue to have the proprietary GRADIUM lens glass technology to offer to certain laser markets.

### Our key indicators:

Usually on a weekly basis, management reviews a number of performance indicators. Some of these indicators are qualitative and others are quantitative. These indicators change from time to time as the opportunities and challenges in the business change. They are mostly non-financial indicators such as units of shippable output by major product line, production yield rates by major product line and the output and yield data from significant intermediary manufacturing processes that support the production of the finished shippable product. These indicators can be used to calculate such other related indicators as fully yielded unit production per-shift, which varies by the particular product and our state of automation in production of that product at any given time. Higher unit production per shift means lower unit cost and therefore improved margins or improved ability to compete where desirable for price sensitive customer applications. The data from these reports is used to determine tactical operating actions and changes. We believe that our non-financial production indicators, such as those noted, are proprietary information.

Financial indicators that are usually reviewed at the same time include the major elements of the micro-level business cycle:

- sales backlog;
- EBITDA;
- inventory levels; and
- accounts receivable levels and quality.

These indicators are similarly used to determine tactical operating actions and changes and are discussed in more detail below.

### Sales Backlog:

Sales growth has been and continues to be our best indicator of success. Our best view into the efficacy of our sales efforts is in our “order book.” Our order book equates to sales “backlog.” It has a quantitative and a qualitative aspect: quantitatively, our backlog’s prospective dollar value and qualitatively, what percent of the backlog is scheduled by the customer for date-certain delivery. We define our “12-month backlog” as that which is requested by the customer for delivery within one year and which is reasonably likely to remain in the backlog and be converted into revenues. This includes customer purchase orders and may include amounts under supply contracts if they meet the aforementioned criteria. Generally, a higher 12-month backlog is better for us.

Our 12-month backlog at December 31, 2014 was approximately $5.59 million compared to $4.27 million as of June 30, 2014. Bookings and quote activity have continued to increase for our industrial low-cost lenses in Asia in the first six months of fiscal 2015, bookings in Asia for our low-cost lenses increased by 29% compared to the first six months of fiscal 2014. We project continued production and shipment growth for these low-cost lenses in Asia during the remainder of fiscal 2015.

We continue to diversify our business by entering into additional markets such as digital imaging, laser tools, telecommunications, digital projectors, industrial equipment, weapon sights and green lasers. We expect to show increases in revenue of our precision molded optics and infrared products for the remainder of fiscal 2015 as a result of this diversification.

### EBITDA:

EBITDA and Adjusted EBITDA are non-GAAP financial measures used by management, lenders and certain investors as a supplemental measure in the evaluation of some aspects of a corporation’s financial position and core operating performance. Investors sometimes use EBITDA as it allows for some level of comparability of profitability trends between those businesses differing as to capital structure and capital intensity by removing the impacts of depreciation and amortization. EBITDA also does not include changes in major working capital items such as receivables, inventory and payables, which can also indicate a significant need for, or source of, cash. Since decisions regarding capital investment and financing and changes in working capital components can have a significant impact on cash flow, EBITDA is not a good indicator of a business’s cash flows. We use EBITDA for evaluating the relative underlying performance of the Company’s core operations and for planning purposes. We calculate EBITDA by adjusting net income (loss) to exclude net interest expense, income tax expense or benefit, depreciation and amortization, thus the term “Earnings Before Interest, Taxes, Depreciation and Amortization” and the acronym “EBITDA.”

We also calculated an Adjusted EBITDA, which excludes the effect of the non-cash expense associated with the mark-to-market adjustments related to our June 2012 Warrants. We believe this Adjusted EBITDA is helpful for investors to better understand the financial results of our business operations.

The following table sets forth EBITDA and Adjusted EBITDA for the six month periods ended December 31, 2014 and 2013:

*(Unaudited)*

|  | Three months ended December 31, 2014 | 2013 | Six months ended December 31, 2014 | 2013 |
| --- | ---: | ---: | ---: | ---: |
| Net income (loss) | $141,213 | $(202,033) | $(437,837) | $(282,378) |
| Depreciation and amortization | 145,899 | 200,542 | 275,222 | 424,490 |
| Interest expense | 7,387 | 5,245 | 23,401 | 10,467 |
| EBITDA | $294,499 | $3,754 | $(139,214) | $152,579 |
| Change in fair value of warrant liability | (534,784) | 35,013 | (480,826) | 53,965 |
| Adjusted EBITDA | $(240,285) | $38,767 | $(620,040) | $206,544 |

Our Adjusted EBITDA for the six months ended December 31, 2014 was approximately ($620,000), compared to approximately $207,000 for the six months ended December 31, 2013. The difference in Adjusted EBITDA between periods was principally caused by a higher net loss recognized in the six months ended December 31, 2014, as well as lower depreciation, offset by higher income related to the change in the fair value of our warrant liability with respect to the June 2012 Warrants during the six months ended December 31, 2014.

### Inventory Levels:

We manage our inventory levels to minimize investment in working capital but still have the flexibility to meet customer demand to a reasonable degree. While the mix of inventory is an important factor, including adequate safety stocks of long lead-time materials, an important aggregate measure of inventory in all phases of production is the quarter’s ending inventory expressed as a number of days worth of the quarter’s cost of sales, also known as “days cost of sales in inventory,” or “DCSI.” It is calculated by dividing the quarter’s ending inventory by the quarter’s cost of goods sold, multiplied by 365 and divided by 4. Generally, a lower DCSI measure equates to a lesser investment in inventory and therefore more efficient use of capital. During the quarter ended December 31, 2014 and 2013, our DCSI was 145 and 154 respectively, compared to an average DCSI of 188 for the year ended June 30, 2014. The decrease in DCSI from the prior fiscal year is due to lower inventory levels, higher revenues, and lower production rates caused by the transition of our operations from our Shanghai facility to our Zhenjiang facility.

### Accounts Receivable Levels and Quality:

Similarly, we manage our accounts receivable to minimize investment in working capital. We measure the quality of receivables by the proportions of the total that are at various increments past due from our normally extended terms, which are generally 30 days. The most important aggregate measure of accounts receivable is the quarter’s ending balance of net accounts receivable expressed as a number of day’s worth of the quarter’s net revenues, also known as “days sales outstanding,” or “DSO.” It is calculated by dividing the quarter’s ending net accounts receivable by the quarter’s net revenues, multiplied by 365 and divided by 4. Generally, a lower DSO measure equates to a lesser investment in accounts receivable, and therefore, more efficient use of capital. For the quarters ended December 31, 2014 and 2013, our DSO was 66 and 73, respectively. During the year ended June 30, 2014, our average DSO was 76. The increase in revenue during the second quarter of fiscal 2015 lowered the DSO; however, 53% of the revenue generated in the second quarter of fiscal 2015 was shipped in the third month of the quarter. For the past two years over 44% of our quarterly sales are shipped in the third month of each quarter. There is less opportunity to collect receivables during any given quarter when a higher percentage is shipped in the last month of the quarter.

### Other Key Indicators:

Other key indicators include various operating metrics, some of which are qualitative and others are quantitative. These indicators change from time to time as the opportunities and challenges in the business change. They are mostly non-financial indicators such as on time delivery trends, units of shippable output by major product line, production yield rates by major product line and the output and yield data from significant intermediary manufacturing processes that support the production of the finished shippable product. These indicators can be used to calculate such other related indicators as fully-yielded unit production per-shift, which varies by the particular product and our state of automation in production of that product at any given time. Higher unit production per shift means lower unit cost and therefore improved margins or improved ability to compete where desirable for price sensitive customer applications. The data from these reports is used to determine tactical operating actions and changes.

#### Results of Operations

### Fiscal Second Quarter: Three months ended December 31, 2014 compared to the three months ended December 31, 2013

### Revenues:

For the quarter ended December 31, 2014, our total revenues increased 15% to $3.35 million compared to $2.91 million for the second quarter of last fiscal year. This increase was attributable to an increase in sales of our precision molded lenses and an increase in sales of infrared products. We expect orders for infrared products and low cost lenses in Asia to continue to grow.

Unit shipment volume in precision molded optics decreased by 18% in the second quarter of fiscal 2015 compared to the same period of the prior fiscal year. This is due to lower unit sales in precision molded optic units with a sales price of less than $5. These lenses are typically for the industrial tool market in China, which has experienced a recent slow down. However, we expect this to recover throughout the remainder of fiscal 2015.

### Cost of Sales:

Our gross margin percentage in the second quarter of fiscal 2015 was 38% compared to 43% for the second quarter of fiscal 2014. Total manufacturing costs of $2.08 million were approximately $415,000 higher in the second quarter of fiscal 2015 compared to the same period of the prior fiscal year given the higher revenues. We also incurred costs due to higher wages associated with the ramp-up in infrared production, the overlapping manufacturing workforces during the transition of production between our two China facilities, and severance for terminated staff at LPOI’s Shanghai facility as we move production to LPOIZ’s Zhenjiang facility.

The increase in our manufacturing costs was offset by 87% of the precision molded optics lenses sold were produced with a less expensive glass type, compared to the second quarter of fiscal 2014, when only 63% of our precision molded optics lenses sold were produced with less expensive glass types.

Direct costs, which include material, labor and services, remained at 31% of revenue in the second quarter of fiscal 2015, as well as in the second quarter of fiscal 2014. The gross margin of 38% in the second quarter of fiscal 2015 was negatively impacted by the severance costs and transition costs between LPOI’s Shanghai facility and LPOIZ’s Zhenjiang facility. We incurred $50,000 of additional expense due to the overlapping staff in both of our China locations while the staff in the Zhenjiang facility continued training during the transition period. If we exclude these severance costs and non-recurring costs of $277,000 for professional service fees for certain strategic growth initiatives from the calculation, the gross margin for the second quarter of fiscal 2015, as adjusted, was 41%. In the long-term, we expect our margins to surpass prior levels as production originates at the LPOIZ facility and volume levels reach optimal rates.

### Selling, General and Administrative:

During the second quarter of fiscal 2015, selling, general and administrative (“SG&A”) costs were approximately $1.33 million, compared to $1.15 million in the second quarter of fiscal 2014, an increase of approximately $171,000. The increase was primarily due to an increase of approximately $277,000 in professional service fees in support of strategic growth initiatives offset by lower stock compensation expenses of $82,000 and lower depreciation expense of $22,000. We generally intend to maintain SG&A costs generally at current levels, notwithstanding the professional service fees incurred for certain strategic growth initiatives from the calculation.

### New Product Development:

New product development costs were approximately $350,000 in the second quarter of fiscal 2015, an increase of $86,000 from the second quarter of fiscal 2014. This increase was due to an increase of $58,000 in wages and an increase of $31,000 in materials used by engineering in support of our infrared product line. We anticipate that these expenses will increase modestly for the remainder of fiscal year 2015 as we invest in the continued development and expansion of our infrared product lines.

### Other Income (Expense):

Interest expense was approximately $7,400 in the second quarter of fiscal 2015 as compared to $5,200 in the second quarter of fiscal 2014. Interest expense resulted from amortization of debt costs related to our credit facility.

In the second quarter of fiscal 2015, we recognized income of approximately $535,000 related to the change in the fair value of warrant liability in connection with our June 2012 private placement. We recognized expense of approximately $35,000 in the same period last year. This fair value will be re-measured each reporting period throughout the five year life of the warrants, or until exercised.

Other income, net was approximately $19,000 in the second quarter of fiscal 2015 compared to approximately $25,000 in the second quarter of fiscal 2014. This was primarily from the effects of foreign currency exchange transactions.

### Net Income (Loss):

Net income was approximately $141,000 or $0.01 basic and diluted earnings per share during the second quarter of fiscal 2015, compared with the second quarter of fiscal 2014, in which we reported a net loss of approximately $202,000 or $0.01 basic and diluted loss per share. The approximate $343,000 increase in net income resulted from an increase in income in the change in the fair value of warrant liability offset by higher professional services fees of $277,000.

Weighted-average shares outstanding (basic) was 14,305,985 in the second quarter of fiscal 2015 compared to 13,863,865 in the second quarter of fiscal 2014. The increase in weighted-average shares outstanding was primarily due to the issuance of shares of common stock related to shares issued under the employee stock purchase plan.

### Fiscal First Half: Six months ended December 31, 2014 compared to the six months ended December 31, 2013

### Revenues:

For the six months ended December 31, 2014, we reported total revenues of $5.97 million compared to $5.72 million for the first half of last fiscal year, an increase of 4%. The increase from the first half of the prior fiscal year was attributable to an increase in sales of our precision molded lenses and a 158% increase in sales of infrared products.

### Cost of Sales:

Our gross margin percentage in the first half of fiscal 2015 was 38%, a decrease from 45% in the first half of fiscal 2014. Total manufacturing costs of $3.71 million were approximately $550,000 higher in the first half of fiscal 2015 compared to the same period of the prior fiscal year given the higher revenue levels. We also incurred costs due to higher wages associated with the ramp-up in infrared production, the overlapping manufacturing workforces during the transition of production between our two China manufacturing facilities, severance for terminated staff at LPOI’s Shanghai facility as we move production to LPOIZ’s Zhenjiang facility.

Unit sales of precision molded optics lenses increased by 20% in the first half of fiscal 2015 compared to the same period last year. Direct costs, which include material, labor and services, increased to 30% of revenue in the first half of fiscal 2015, as compared to 26% of revenue in the first half of fiscal 2014. The increase in direct costs was primarily due to reclassification of tooling costs. These costs were previously classified as costs of sales overhead but tooling labor is now classified as direct labor.

### Selling, General and Administrative:

During the first half of fiscal 2015, SG&A costs were approximately $2.47 million, compared to $2.23 million in the first half of fiscal 2014, an increase of approximately $238,000. The increase was primarily due to an increase of approximately $268,000 in professional fees in support of strategic growth initiatives offset by $42,000 in lower depreciation expense. We intend to maintain SG&A costs generally at current levels excluding the increase in professional fees, with some increases expected for sales and marketing.

### New Product Development:

New product development costs were approximately $694,000 in the first half of fiscal 2015 compared to $559,000 in the first half of fiscal 2014, an increase of $135,000. This increase was due to an increase of $144,000 in wages for infrared product development offset by a decrease of $20,000 for consulting services.

### Other Income (Expense):

Interest expense was approximately $23,000 in the first half of fiscal 2015 as compared to $10,000 in the first half of fiscal 2014. Interest expense this year resulted from amortization of debt costs related to our credit facility.

In the first half of fiscal 2015 we recognized income of approximately $481,000 related to the change in the fair value of warrant liability in connection with our June 2012 private placement. We recognized expense of $54,000 in the same period last year. This fair value will be re-measured each reporting period throughout the five year life of the warrants, or until exercised.

Other income, net was approximately $20,000 in the first half of fiscal 2015 compared to approximately $30,000 in the first half of fiscal 2014. For the first half of fiscal 2015, other income was primarily comprised of the foreign currency exchange transactions.

### Net Income (Loss):

Net loss was approximately $438,000 or $0.03 basic and diluted loss per share during the first half of fiscal 2015, compared with the first half of fiscal 2014, in which we reported a net loss of approximately $282,000 or $0.02 basic and diluted loss per share. The approximate $155,000 increase in net loss resulted from the change in the fair value of our warrant liability for our June 2012 Warrants and lower gross margin due to the severance costs offset by higher SG&A expenses due to the extraordinary non-recurring professional service fees incurred in support of strategic growth iniatives.

Weighted-average shares outstanding (basic) was 14,297,807 in the first half of fiscal 2015 compared to 13,715,789 in the first half of fiscal 2014. The increase in weighted-average shares outstanding was primarily due to the issuance of shares of common stock related to shares issued under the employee stock purchase plan.

### Liquidity and Capital Resources

At December 31, 2014, we had working capital of $4.0 million and total cash and cash equivalents of $795,000, of which $402,000 of the total cash was held by our foreign subsidiaries. Total cash and cash equivalents decreased during the first half of 2015 primarily due to capital expenditures to expand and improve our manufacturing processes. On February 2, 2015, we had a book cash balance of $1.12 million.

We generally rely on cash from operations and equity and debt offerings, to the extent available, to satisfy our liquidity needs. From February 1996 (when our initial public offering occurred) through the end of our fiscal 2014, inclusive, we have raised a net total of approximately $105 million from the issuance of common and preferred stock, the sale of convertible debt and the exercise of options and warrants for our common stock.

On December 23, 2014, we entered into the Amended Loan and Security Agreement with Avidbank for an Invoice Based Line. The Amended LSA amends and restates that certain Loan and Security Agreement between the Company and Avidbank dated September 30, 2013. Pursuant to the Amended LSA, Avidbank will, in its discretion, make loan advances to the Company up to a maximum aggregate principal amount outstanding not to exceed the lesser of (i) One Million Dollars ($1,000,000) or (ii) eighty percent (80%) of the aggregate balance of the Company’s eligible accounts receivable, also known as the Maximum Advance Rate, as determined by Avidbank in accordance with the Amended LSA. Avidbank may, in its discretion, elect to not make a requested advance, determine that certain accounts are not eligible accounts, change the Maximum Advance Rate or apply a lower advance rate to particular accounts and terminate the Amended LSA.

Amounts borrowed under the Amended LSA may be repaid and re-borrowed at any time prior to December 23, 2015, at which time all amounts shall be immediately due and payable. The advances under the Amended LSA bear interest, on the outstanding daily balance, at a per annum rate equal to three percent (3%) above the Prime Rate (6.25% at December 31, 2014). Interest payments are due and payable on the last business day of each month. Payments received with respect to accounts upon which advances are made will be applied to the amounts outstanding under the Amended LSA.

The Company’s obligations under the Amended LSA are secured by a first priority security interest (subject to permitted liens) in cash, U.S. inventory and accounts receivable. In addition, the Company’s wholly-owned subsidiary, Geltech, has guaranteed the Company’s obligations under the Amended LSA.

The Amended LSA contains customary covenants, including, but not limited to: (i) limitations on the disposition of property; (ii) limitations on changing the Company’s business or permitting a change in control; (iii) limitations on additional indebtedness or encumbrances; (iv) restrictions on distributions; and (v) limitations on certain investments.

Late payments are subject to a late fee equal to the lesser of five percent (5%) of the unpaid amount or the maximum amount permitted to be charged under applicable law. Amounts outstanding during an event of default accrue interest at a rate of five percent (5%) above the interest rate applicable immediately prior to the occurrence of the event of default. The Amended LSA contains other customary provisions with respect to events of default, expense reimbursement, and confidentiality. The amount drawn on the Amended LSA was $473,451 as of December 31, 2014.

Management has developed an operating plan for fiscal 2015 and believes we have adequate financial resources to achieve this plan and to sustain our current operations in the coming year. We have established milestones that will be tracked to ensure that as funds are expended we are achieving results before additional funds are committed. The fiscal 2015 operating plan and related financial projections we have developed anticipate sales growth primarily from precision molded optics, with the emphasis on low-cost, high-volume applications, optical assemblies including our redesigned collimator product line and infrared products. We expect further margin improvements based on production efficiencies and reductions in product costs as a result of the shifting of our manufacturing operations to Shanghai and Zhenjiang, as well as yield improvements, improved tool life and expanded coating capability. Through these actions and our continuing cost reduction programs, we are improving our competitive position in the marketplace.

Our future capital requirements will depend on many factors including a decline in revenue or a lack of anticipated sales growth, increased material costs, increased labor costs, planned production efficiency improvements not being realized, increases in property, casualty, benefit and liability insurance premiums and increases in other discretionary spending, particularly sales and marketing related. We will also continue efforts to keep costs under control as we seek renewed sales growth. Our efforts are directed toward reaching positive cash flow and profitability. If these efforts are not successful, we will need to raise additional capital. Should capital not be available to us at reasonable terms, other actions may become necessary in addition to cost control measures and continued efforts to increase sales. These actions may include exploring strategic options for the sale of the Company, the sale of certain product lines, the creation of joint ventures or strategic alliances under which we will pursue business opportunities, the creation of licensing arrangements with respect to our technology, or other alternatives.

### Sources and Uses of Cash

#### Cash Flows – Financings:

Net cash provided by financing activities was approximately $318,000 in the first half of fiscal 2015 compared to net cash provided by financing activities of approximately $1.54 million in fiscal 2014. In fiscal 2015, we drew a net of approximately $309,000 on our line of credit. In fiscal 2014, we received approximately $1.5 million in the exercise of warrants, net of costs. In connection with the exercise of warrants, we issued 1,136,143 shares of Class A common stock. The exercise prices ranged from $0.87 to $1.89 per share of Class A common stock.

In the fourth quarter of fiscal 2014, we entered into the SPA with Pudong, with respect to a private placement of our Class A common stock. The SPA was subsequently amended and assigned to Pudong Investment.

On January 20, 2015, we sold to Pudong Investment 930,790 shares of Class A common stock at a price of $1.40 per share, which was adjusted from the initial per share purchase price of $1.62 pursuant to the terms of the SPA. The Company received gross cash proceeds from the issuance of the Class A common stock in the amount of approximately $1,303,106. The Company intends to use the proceeds of the sale to provide working capital in support of its continue growth, particularly new product development, sales and marketing of its infrared product line, and capital expenditures related to the acquisition of new equipment.

#### Cash Flows – Operating and Investing:

Cash flow used in operations was approximately $310,000 for the six months ended December 31, 2014, an increase of approximately $92,000 from the first half of fiscal 2014. This increase was primarily due to our net loss, offset by an improvement in working capital due to our management of accounts receivable, inventory and accounts payable. Our fiscal 2015 operating plan and related financial projections anticipate improvement in our cash flows provided by operations in future years due to sales growth and continuing margin improvements based on production efficiencies and reductions in product costs, offset by marginal increases in selling, administrative and new product development expenditures. For example, we expect lower glass costs as a result of replacing internally fabricated material with purchased materials from suppliers in Asia and lower coating costs due to larger unit volumes and due to our ability to coat the lenses in-house rather than out-sourcing this service.

During the first half of fiscal 2015, we expended approximately $410,000 for capital equipment as compared to $942,000 during the first half of fiscal 2014. The majority of our capital expenditures during both fiscal 2015 and fiscal 2014 were related to the purchase of equipment used to enhance or expand our production capacity, tooling for our precision molded products and equipment and facility improvements for our new facility in Zhenjiang. We anticipate lower expenditures during fiscal 2015; however, the total amount expended will depend on opportunities and circumstances.

### Off Balance Sheet Arrangements

We do not engage in any activities involving variable interest entities or off-balance sheet arrangements.

### Critical Accounting Policies and Estimates:

**Allowance for accounts receivable** is calculated by taking 100% of the total of invoices that are over 90 days past due from due date and 10% of the total of invoices that are over 60 days past due from the due date for U.S. based accounts and 100% on invoices that are over 120 days past due for China based accounts. Accounts receivable are customer obligations due under normal trade terms. The Company performs continuing credit evaluations of its customers’ financial condition. Recovery of bad debt amounts which were previously written off is recorded as a reduction of bad debt expense in the period the payment is collected. If the Company’s actual collection experience changes, revisions to its allowance may be required. After attempts to collect a receivable have failed, the receivable is written off against the allowance.

**Inventory obsolescence reserve** is calculated by reserving 100% for items that have not been sold in two years or that have not been purchased in two years and 25% for products which we have more than a two year supply, as well as reserving 50% for other items deemed to be slow moving within the last 12 months and reserving 25% for items deemed to have low material usage within the last six months.

**Revenue** is recognized from product sales when products are shipped to the customer, provided that the Company has received a valid purchase order, the price is fixed, title has transferred, collection of the associated receivable is reasonably assured, and there are no remaining significant obligations. Revenues from product development agreements are recognized as milestones as completed in accordance with the terms of the agreements and upon shipment of products, reports or designs to the customer. Invoiced amounts for value-added taxes (VAT) related to sales are posted to the balance sheet and not included in revenue.

**Stock based compensation** is measured at grant date, based on the fair value of the award, and is recognized as an expense over the employee’s requisite service period. We estimate the fair value of each stock option as of the date of grant using the Black-Scholes-Merton pricing model. Most options granted under the Plan vest ratably over two to four years and generally have ten-year contract lives. The volatility rate is based on four-year historical trends in common stock closing prices and the expected term was determined based primarily on historical experience of previously outstanding options. The interest rate used is the U.S. Treasury interest rate for constant maturities. The likelihood of meeting targets for option grants that are performance based are evaluated each quarter. If it is determined that meeting the targets is probable then the compensation expense will be amortized over the remaining vesting period.

## Controls and procedures

As filed, 1,008 characters.

Under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, we evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”)) as of December 31, 2014, the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of December 31, 2014 in reporting on a timely basis information required to be disclosed by us in the reports we file or submit under the Exchange Act.

During the fiscal quarter ended December 31, 2014, there was no change in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Filed Feb 5, 2015.
Source: SEC EDGAR, the filing index for accession 0001387131-15-000371. Last ingested by Listed: Nov 11, 2026, 01:28 ET. No prices; not investment advice.
